251 related articles for article (PubMed ID: 33325835)
1. ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development Study.
Hua X; Li C; Pogue JM; Sharma VS; Karaiskos I; Kaye KS; Tsuji BT; Bergen PJ; Zhu Y; Song J; Li J
JMIR Mhealth Uhealth; 2020 Dec; 8(12):e20525. PubMed ID: 33325835
[TBL] [Abstract][Full Text] [Related]
2. Correction: ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development Study.
Hua X; Li C; Pogue JM; Sharma VS; Karaiskos I; Kaye KS; Tsuji BT; Bergen PJ; Zhu Y; Song J; Li J
JMIR Mhealth Uhealth; 2020 Dec; 8(12):e26593. PubMed ID: 33338026
[TBL] [Abstract][Full Text] [Related]
3. Dosing guidance for intravenous colistin in critically-ill patients.
Nation RL; Garonzik SM; Thamlikitkul V; Giamarellos-Bourboulis EJ; Forrest A; Paterson DL; Li J; Silveira FP
Clin Infect Dis; 2017 Mar; 64(5):565-571. PubMed ID: 28011614
[TBL] [Abstract][Full Text] [Related]
4. Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii.
Luque S; Grau S; Valle M; Sorlí L; Horcajada JP; Segura C; Alvarez-Lerma F
Int J Antimicrob Agents; 2013 Aug; 42(2):178-81. PubMed ID: 23769664
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and pharmacokinetics of colistimethate sodium and colistin in critically ill patients in an Indian hospital with high endemic rates of multidrug-resistant Gram-negative bacterial infections: A prospective observational study.
Moni M; Sudhir AS; Dipu TS; Mohamed Z; Prabhu BP; Edathadathil F; Balachandran S; Singh SK; Prasanna P; Menon VP; Patel T; Patel P; Kaye KS; Menon VP
Int J Infect Dis; 2020 Nov; 100():497-506. PubMed ID: 32781161
[TBL] [Abstract][Full Text] [Related]
6. Multicenter Population Pharmacokinetic Study of Colistimethate Sodium and Colistin Dosed as in Normal Renal Function in Patients on Continuous Renal Replacement Therapy.
Leuppi-Taegtmeyer AB; Decosterd L; Osthoff M; Mueller NJ; Buclin T; Corti N
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30478168
[TBL] [Abstract][Full Text] [Related]
7. Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients.
Karaiskos I; Friberg LE; Pontikis K; Ioannidis K; Tsagkari V; Galani L; Kostakou E; Baziaka F; Paskalis C; Koutsoukou A; Giamarellou H
Antimicrob Agents Chemother; 2015 Dec; 59(12):7240-8. PubMed ID: 26369974
[TBL] [Abstract][Full Text] [Related]
8. Systemic pharmacokinetics and safety of high doses of nebulized colistimethate sodium in critically ill patients with hospital-acquired and ventilator-associated pneumonia.
Benítez-Cano A; de Antonio-Cuscó M; Luque S; Sorlí L; Carazo J; Ramos I; Bermejo S; Campillo N; Horcajada JP; Samsó E; Grau S
J Antimicrob Chemother; 2019 Nov; 74(11):3268-3273. PubMed ID: 31495877
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients.
Garonzik SM; Li J; Thamlikitkul V; Paterson DL; Shoham S; Jacob J; Silveira FP; Forrest A; Nation RL
Antimicrob Agents Chemother; 2011 Jul; 55(7):3284-94. PubMed ID: 21555763
[TBL] [Abstract][Full Text] [Related]
10. Population Pharmacokinetics of Intravenous Colistin in Pediatric Patients: Implications for the Selection of Dosage Regimens.
Ooi MH; Ngu SJ; Chor YK; Li J; Landersdorfer CB; Nation RL
Clin Infect Dis; 2019 Nov; 69(11):1962-1968. PubMed ID: 30722017
[TBL] [Abstract][Full Text] [Related]
11. Intravenous colistimethate (colistin) use in critically ill children without cystic fibrosis.
Falagas ME; Sideri G; Vouloumanou EK; Papadatos JH; Kafetzis DA
Pediatr Infect Dis J; 2009 Feb; 28(2):123-7. PubMed ID: 19116601
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of Colistin Following a Single Dose of Intravenous Colistimethate Sodium in Critically Ill Neonates.
Nakwan N; Usaha S; Chokephaibulkit K; Villani P; Regazzi M; Imberti R
Pediatr Infect Dis J; 2016 Nov; 35(11):1211-1214. PubMed ID: 27276179
[TBL] [Abstract][Full Text] [Related]
13. Colistin Use in Patients With Reduced Kidney Function.
Fiaccadori E; Antonucci E; Morabito S; d'Avolio A; Maggiore U; Regolisti G
Am J Kidney Dis; 2016 Aug; 68(2):296-306. PubMed ID: 27160031
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic Dosing for Critically Ill Adult Patients Receiving Intermittent Hemodialysis, Prolonged Intermittent Renal Replacement Therapy, and Continuous Renal Replacement Therapy: An Update.
Hoff BM; Maker JH; Dager WE; Heintz BH
Ann Pharmacother; 2020 Jan; 54(1):43-55. PubMed ID: 31342772
[No Abstract] [Full Text] [Related]
15. A Monte Carlo Simulation Approach for Beta-Lactam Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy.
Jang SM; Gharibian KN; Lewis SJ; Fissell WH; Tolwani AJ; Mueller BA
J Clin Pharmacol; 2018 Oct; 58(10):1254-1265. PubMed ID: 29746711
[TBL] [Abstract][Full Text] [Related]
16. Population Pharmacokinetics of Colistin Methanesulfonate and Colistin in Critically Ill Patients with Acute Renal Failure Requiring Intermittent Hemodialysis.
Jacobs M; Grégoire N; Mégarbane B; Gobin P; Balayn D; Marchand S; Mimoz O; Couet W
Antimicrob Agents Chemother; 2016 Jan; 60(3):1788-93. PubMed ID: 26729492
[TBL] [Abstract][Full Text] [Related]
17. Single- and multiple-dose pharmacokinetics and total removal of colistin in critically ill patients with acute kidney injury undergoing prolonged intermittent renal replacement therapy.
Schmidt JJ; Strunk AK; David S; Bode-Böger SM; Martens-Lobenhoffer J; Knitsch W; Scherneck S; Welte T; Kielstein JT
J Antimicrob Chemother; 2019 Apr; 74(4):997-1002. PubMed ID: 30624668
[TBL] [Abstract][Full Text] [Related]
18. Optimizing colistin dosing: Is a loading dose necessary?
Nazer LH; Anabtawi N
Am J Health Syst Pharm; 2017 Jan; 74(1):e9-e16. PubMed ID: 28007716
[TBL] [Abstract][Full Text] [Related]
19. Colistin: understanding and applying recent pharmacokinetic advances.
Ortwine JK; Kaye KS; Li J; Pogue JM
Pharmacotherapy; 2015 Jan; 35(1):11-6. PubMed ID: 25187500
[TBL] [Abstract][Full Text] [Related]
20. [Changes in the dosing of colistimethate sodium in critically ill patients].
Ortega-García MP; Abril-López de Medrano V; Gimeno-Cardona C
Rev Esp Quimioter; 2016 Feb; 29(1):53-4. PubMed ID: 26785228
[No Abstract] [Full Text] [Related]
[Next] [New Search]
